In this study, we could confirm that the whole-body PSMA-TVs calculated using PBT were altogether lower compared to the other applied thresholding methods, with the exception of Multiotsu (Fig. 2: higher tumor volume compared to baseline method led to a flatter course of the linear correlation). The gene discussed is FOLH1; the disease is neoplasm.